756 related articles for article (PubMed ID: 17767552)
1. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
4. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
5. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
6. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease.
Park KS; Park JS; Nam JH; Bang D; Sohn S; Lee ES
Tissue Antigens; 2007 Feb; 69(2):139-44. PubMed ID: 17257316
[TBL] [Abstract][Full Text] [Related]
7. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
9. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
10. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
11. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
12. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.
Park KS; Park JH; Song YW
Tissue Antigens; 2008 Oct; 72(4):342-6. PubMed ID: 18700876
[TBL] [Abstract][Full Text] [Related]
14. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
15. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
16. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
Sullivan LC; Clements CS; Rossjohn J; Brooks AG
Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
[TBL] [Abstract][Full Text] [Related]
17. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
de Matos CT; Berg L; Michaëlsson J; Felländer-Tsai L; Kärre K; Söderström K
Immunology; 2007 Oct; 122(2):291-301. PubMed ID: 17521371
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
[TBL] [Abstract][Full Text] [Related]
19. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
Gunturi A; Berg RE; Crossley E; Murray S; Forman J
Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
